Recombinant Rat DLL4 Protein，His

DLL4 (Delta-like ligand 4) is a critical member of the Notch signaling pathway, which plays a pivotal role in various biological processes, including embryonic development, cell differentiation, and immune responses. Research on DLL4 recombinant protein has gained prominence due to its essential role in endothelial cell biology and angiogenesis. DLL4 is primarily involved in regulating the balance between sprouting and stabilization of blood vessels, making it a potential target for therapeutic interventions in cancer and other diseases characterized by aberrant angiogenesis. Early studies indicated that DLL4 functions as a ligand for Notch receptors, influencing the fate of neighboring endothelial cells, thereby impacting blood vessel formation and function. Furthermore, DLL4 has been identified as a key factor in the regulation of tumor vasculature, with its expression being associated with poor prognosis in various cancers. Given its significance, scientists have focused on developing DLL4 recombinant proteins to investigate their biological functions and therapeutic potential. These recombinant proteins serve as valuable tools for elucidating the molecular mechanisms underlying DLL4's role in angiogenesis, as well as for developing DLL4-targeted therapies, including monoclonal antibodies and small molecules. By harnessing DLL4's biological properties, researchers aim to create innovative strategies for treating disorders linked to abnormal blood vessel formation, thereby paving the way for advanced cancer therapies and regenerative medicine approaches.